A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide.
Glynn SA et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2009